Oregon’s Jackson County Hosts Hearing On Amendments For Psilocybin Services Centers, ‘Opt-Out’ Vote
“Never a dull moment in the psychedelics space,” says Silo Wellness (OTCQB: SILFF) founder and CEO Mike Arnold.
EXCLUSIVE: Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says ‘Potential Reward Is Immeasurable’
Brock Pierce, the crypto billionaire, economist and philanthropist serving as chairman of the Bitcoin Foundation, has joined Jeremy Gardner’s psychedelics-focused venture fund Mystic Ventures as a general partner, Benzin
Legal Mushroom Products From Amanita Muscaria Shipped To 37 US States
Canadian-based producer of mushroom-derived health supplements Psyched Wellness Ltd.
Florida’s Growing Psychedelic Treatment Options: Healthcare Company Expands Network Of Clinics
Senior health brand Irwin Naturals Inc.
Psychedelic Therapy Frontiers Podcast Is Back, Check Out Upcoming Episodes
Mental health care company Numinus Wellness (OTCQX: NUMIF) is re-launching its "Psychedelic Therapy Frontiers" podcast series dedicated to exploring the psychedelics renaissance and cultivating mind, body and spiritual health with new hosts, expanded topics and fr
Ketamine Therapy: Revitalist’s New Financing Option, Irwin Naturals Expands Chain Of Clinics
Revitalist Increases Patient Access By Financing Costs With M-Lend Financial
Psyched: Top Psychedelics Execs., 50% Of Americans Support Medical Psychedelics, Cary Grant’s LSD Therapy & More
15 Global Psychedelics Executives To Keep An Eye On In 2022
EXCLUSIVE: Insider’s Peek At Mammoth Of Psychedelics VCs, Palo Santo’s Investment Fundamentals & Specificities
(Part one of a four-part series)
Australian Psychedelics: Incannex Business & Financials, New Research Center For Mushrooms & Eating Disorders
Clinical-stage biopharma company Incannex Healthcare Ltd. (NASDAQ: IXHL) shared its quarterly activities report and appendix 4C for the period ended 30 September 2022, noticeably applying for several U.S.
Mental Health Provider Expands Psychedelic-Assisted Therapy For Chronic & Serious Medical Illnesses
Numinus Wellness Inc. (OTCQX: NUMIF) announced the launch of its new clinical program, ketamine for chronic and serious medical illness, to be first introduced at Utah, BC and Quebec clinics and then expanded to Numinus' remaining facilities.